|
Market Closed -
London S.E.
11:35:16 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.1150 GBX | +4.55% |
|
+4.55% | -46.51% |
| 10-14 | WINNERS & LOSERS: 80 Mile up as US president plots Greenland exploring | AN |
| 09-03 | Futura Medical's fundraise and formal sale process | AN |
Company Valuation: Oxford BioDynamics Plc
Data adjusted to current consolidation scope
| Fiscal Period: September | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Market Cap 1 | 86.3 | 12.07 | 10.65 | 18.46 |
| Change | - | -86.02% | -11.72% | 73.32% |
| Enterprise Value (EV) 1 | 86.3 | 12.07 | 10.65 | 22.1 |
| Change | - | -86.02% | -11.72% | 107.42% |
| P/E | -5.07x | - | -0.59x | - |
| PBR | - | - | - | 0.01x |
| PEG | - | - | - | - |
| Capitalization / Revenue | - | 15.9x | 8.53x | 9.76x |
| EV / Revenue | - | 15.9x | 8.53x | 11.7x |
| EV / EBITDA | - | - | -1.03x | -2.51x |
| EV / EBIT | - | - | -0.84x | -2.04x |
| EV / FCF | - | - | - | -2.44x |
| FCF Yield | - | - | - | -40.9% |
| Dividend per Share 3 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 3 | -0.073 | - | -0.008 | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 0.7597 | 1.249 | 1.891 |
| EBITDA 1 | - | - | -10.32 | -8.814 |
| EBIT 1 | - | - | -12.63 | -10.82 |
| Net income | -12.65 | - | -12.72 | - |
| Net Debt 1 | - | - | - | 3.633 |
| Reference price 3 | 0.370000 | 0.032200 | 0.004750 | 0.001150 |
| Nbr of stocks (in thousands) | 202,303 | 311,856 | 1,957,578 | 13,440,911 |
| Announcement Date | 2/22/24 | 3/5/25 | 12/16/25 | - |
1GBP in Million2EUR in Million3GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 11.68x | -2.51x | - | 20.68M | |
| 37.06x | 13.1x | 27.8x | 0.54% | 1,135B | |
| 38.61x | 6.49x | 18.27x | 2.02% | 635B | |
| 36.46x | 8.38x | 17.29x | 2.41% | 505B | |
| 20.87x | 5.11x | 12.73x | 2.56% | 378B | |
| 105.89x | 5.92x | 25.41x | 2.34% | 358B | |
| 21.76x | 5.68x | 13.94x | 2.81% | 295B | |
| 22.43x | 4.53x | 12.94x | 1.95% | 266B | |
| 27.87x | 7.16x | 12.81x | 2.3% | 237B | |
| -45.48x | 6.98x | 27.06x | 2.11% | 193B | |
| Average | 29.50x | 7.50x | 16.57x | 2.12% | 400.37B | |
| Weighted average by Cap. | 35.23x | 8.29x | 20.39x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OBD Stock
- Valuation Oxford BioDynamics Plc
Select your edition
All financial news and data tailored to specific country editions
